Legis Daily

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

USA119th CongressHR-124| House 
| Updated: 1/3/2025
Al Green

Al Green

Democratic Representative

Texas

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill aims to enhance awareness of renal medullary carcinoma (RMC) among individuals with sickle cell disease who are enrolled in Medicaid . It seeks to achieve this by providing financial incentives to states for offering educational services related to RMC risk. Specifically, the legislation amends Section 1903(a)(3)(E)(ii) of the Social Security Act, which governs federal medical assistance percentages. By inserting "renal medullary carcinoma" into the existing text, the bill ensures that states can receive enhanced federal matching funds for expenditures related to educating Medicaid beneficiaries with sickle cell disease about the risks of RMC. This change is intended to promote early detection and improved health outcomes for this vulnerable population.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 117-124
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021

Bill from Previous Congress

HR 118-124
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Bill from Previous Congress

HR 116-148
Byron Nash Renal Medullary Carcinoma Awareness Act of 2019
Jan 3, 2025
Introduced in House
Jan 3, 2025
Referred to the House Committee on Energy and Commerce.
  • Bill from Previous Congress

    HR 117-124
    Byron Nash Renal Medullary Carcinoma Awareness Act of 2021


  • Bill from Previous Congress

    HR 118-124
    Byron Nash Renal Medullary Carcinoma Awareness Act of 2023


  • Bill from Previous Congress

    HR 116-148
    Byron Nash Renal Medullary Carcinoma Awareness Act of 2019


  • January 3, 2025
    Introduced in House


  • January 3, 2025
    Referred to the House Committee on Energy and Commerce.

Health

CancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

USA119th CongressHR-124| House 
| Updated: 1/3/2025
This bill aims to enhance awareness of renal medullary carcinoma (RMC) among individuals with sickle cell disease who are enrolled in Medicaid . It seeks to achieve this by providing financial incentives to states for offering educational services related to RMC risk. Specifically, the legislation amends Section 1903(a)(3)(E)(ii) of the Social Security Act, which governs federal medical assistance percentages. By inserting "renal medullary carcinoma" into the existing text, the bill ensures that states can receive enhanced federal matching funds for expenditures related to educating Medicaid beneficiaries with sickle cell disease about the risks of RMC. This change is intended to promote early detection and improved health outcomes for this vulnerable population.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 117-124
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021

Bill from Previous Congress

HR 118-124
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Bill from Previous Congress

HR 116-148
Byron Nash Renal Medullary Carcinoma Awareness Act of 2019
Jan 3, 2025
Introduced in House
Jan 3, 2025
Referred to the House Committee on Energy and Commerce.
  • Bill from Previous Congress

    HR 117-124
    Byron Nash Renal Medullary Carcinoma Awareness Act of 2021


  • Bill from Previous Congress

    HR 118-124
    Byron Nash Renal Medullary Carcinoma Awareness Act of 2023


  • Bill from Previous Congress

    HR 116-148
    Byron Nash Renal Medullary Carcinoma Awareness Act of 2019


  • January 3, 2025
    Introduced in House


  • January 3, 2025
    Referred to the House Committee on Energy and Commerce.
Al Green

Al Green

Democratic Representative

Texas

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
CancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid